Bibliography
- Buchwald H, Varco RL, Matts JP et al.: Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N. Engl. J. Med. 323(14), 946–955 (1990).
- Buchwald H, Varco RL, Boen JR et al.: Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias. Arch. Intern. Med. 158(11), 1253–1261 (1998).
- Reihner E, Bjorkhem I, Angelin B, Ewerth S, Einarsson K: Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7 α-hydroxylase activity. Gastroenterology 97(6), 1498–1505 (1989).
- Koivisto PV, Miettinen TA: Effect of ileal exclusion on kinetics of very low density lipoprotein triglycerides in familial hypercholesterolemia. Clin. Chim. Acta 161(1), 91–101 (1986).
- Buchwald H, Rudser KD, Williams SE, Michalek VN, Vagasky J, Connett JE: Overall mortality, incremental life expectancy and cause of death in the Program on the Surgical Control of the Hyperlipidemia. Annal. Surg. 241, 1034–1040 (2010).
- Kjekshus J, Apetrei E, Barrios V et al.: Rosuvastatin in older patients with systolic heart failure. N. Engl. J. Med. 357(22), 2248–2261 (2007).
- Tavazzi L, Maggioni AP, Marchioli R et al.: Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372(9645), 1231–1239 (2008).
- Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360(9326), 7–22 (2002).
- Shepherd J, Blauw GJ, Murphy MB et al.: Pravastatin in Elderly Individuals at Risk of Vascular Disease (PROSPER): a randomised controlled trial. Lancet 360(9346), 1623–1630 (2002).
- The Lipid Research Clinics Coronary Primary Prevention Trial results II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251(3), 365–374 (1984).